A Comparative Analysis of Attitudes on Communication Toward Stem Cell Research and Regenerative Medicine Between the Public and the Scientific Community

Author:

Shineha Ryuma1,Inoue Yusuke2,Ikka Tsunakuni3,Kishimoto Atsuo4,Yashiro Yoshimi5

Affiliation:

1. a Seijo University, Setagaya, Tokyo, Japan

2. b University of Tokyo, Minato-ku, Tokyo, Japan

3. c National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan

4. d Osaka University, Suita, Osaka, Japan

5. e Kyoto University, Sakyo-ku, Kyoto, Japan

Abstract

Abstract Owing to the rapid progress in stem cell research (SCR) and regenerative medicine (RM), society's expectation and interest in these fields are increasing. For effective communication on issues concerning SCR and RM, surveys for understanding the interests of stakeholders is essential. For this purpose, we conducted a large-scale survey with 2,160 public responses and 1,115 responses from the member of the Japanese Society for Regenerative Medicine. Results showed that the public is more interested in the post-realization aspects of RM, such as cost of care, countermeasures for risks and accidents, and clarification of responsibility and liability, than in the scientific aspects; the latter is of greater interest only to scientists. Our data indicate that an increased awareness about RM-associated social responsibility and regulatory framework is required among scientists, such as those regarding its benefits, potential accidents, abuse, and other social consequences. Awareness regarding the importance of communication and education for scientists are critical to bridge the gaps in the interests of the public and scientists.

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,General Medicine

Reference41 articles.

1. Familiarity and prudence of the Japanese public with research into induced pluripotent stem cells, and their desire for its proper regulation;Shineha;Stem Cell Rev,2010

2. Feature 2. New developments in regenerative medicine and innovative drugs using human iPS cells. White Paper on Science and Technology 2013;MEXT,2017

3. New Japanese initiatives on stem cell therapies;Konomi;Cell Stem Cell,2015

4. Recent court ruling in Japan exemplifies another layer of regulation for regenerative therapy;Ikka;Cell Stem Cell,2015

5. International Society for Stem Cell Research: Guidelines for stem cell research and clinical translation 2016,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3